Clinical trials and research in skin cancer
The Stanford Skin Cancer Program offers clinical trials for treatment of advanced melanoma. Stanford is an active participant in the Eastern Cooperative Oncology Group (ECOG) multicenter clinical trials for melanoma, and a number of studies are open for patients with regional nodal metastasis and disseminated disease. Collaboration with our premier basic science departments will continue to provide new techniques and insights in the diagnosis and treatment of melanoma.
Doctors at the Stanford Skin Cancer Program are involved in clinical trials which allow patients access to treatments not yet available elsewhere.
Before beginning treatment, ask your doctor about any clinical trials you should consider. Learn more about clinical trials for cancer patients.
Clinical trial eligibility flowcharts
Eligibility flowcharts map clinical trials to specific types of cancers to determine if a participant is eligible for the particular clinical trial. View all skin cancer eligibility flowcharts at the Stanford Cancer Institute.